Caloric restriction

Caloric restriction is a sustained reduction in energy intake, usually 20 to 40 per cent below what an animal would eat freely, while maintaining adequate vitamins, minerals and protein. In laboratory rodents it remains the most reproducible intervention in biogerontology: it extends median and maximum lifespan and delays most age-related pathologies. In primates the evidence genuinely conflicts, and in humans it stops at intermediate biomarkers measured over two years.

§Origins

Underfeeding was linked to longevity before anyone had a mechanism. Clive McCay's 1935 experiments at Cornell showed that rats fed a restricted but nutritionally complete diet from weaning grew more slowly, matured later and lived substantially longer than freely fed controls.¹ For decades the effect was attributed first to slowed growth, then to reduced metabolic rate, then to reduced oxidative damage. None of those explanations survived scrutiny. Restricted animals do not, in general, have lower mass-specific metabolic rates, and the free-radical account has weakened along with the wider retreat of that theory in mitochondrial biology.

The current framing is nutrient sensing, which most catalogues of the Hallmarks of aging list as a distinct axis. That framing owes much to invertebrate genetics. Cynthia Kenyon's laboratory showed that partial loss of a single insulin/IGF-1-family receptor doubles nematode lifespan, which gave nutrient sensing a demonstrated control point instead of a correlation. Restriction reduces signalling through insulin and IGF-1, lowers mTORC1 output, activates AMPK and raises Autophagy, engaging the same targets that Rapamycin and biguanides address pharmacologically. It also lowers markers of Inflammaging and, in rodents, reduces the burden of senescent cells that senolytic drugs are designed to remove. Work in flies and mice complicates even this account. Restricting protein, or the single amino acid methionine, reproduces much of the effect without reducing calories at all, which suggests that the operative variable is nutrient composition rather than energy as such.²

§The primate studies

Two long-running rhesus macaque experiments produced opposite headline results, and the effort to reconcile them is the most instructive episode in the field.

A joint reanalysis by both teams concluded that the divergence came largely from the controls and the diets rather than from the restriction.³ The NIA control animals were already portion-fed and lean, so that study compared moderate restriction with mild restriction, not with overfeeding. The Wisconsin control diet was higher in sucrose. In practice, then, "caloric restriction extends lifespan" may mean "avoiding chronic overfeeding on a poor diet extends lifespan", a considerably weaker and more ordinary claim.

§Human evidence

CALERIE remains the only randomized controlled trial of sustained restriction in healthy, non-obese adults. Participants were asked for 25 per cent restriction over two years and on average achieved roughly half that, which is itself a finding about adherence. The intervention improved cardiometabolic risk markers, reduced inflammatory markers and produced changes in thymic tissue consistent with reduced immune aging.⁴ It also reduced bone mineral density and lean mass.

A secondary analysis applying DNA-methylation clocks found a small slowing of one pace-of-aging measure and no significant change in the other clocks tested.⁵ The result is often reported as evidence that restriction slows human aging. A more accurate description is that a two-year dietary change moved one composite predictor by a small amount, and the relationship between that predictor and any clinical outcome is still unestablished. That general problem is addressed under Aging biomarkers and Biological age.

What has not been shown

No human study has tested whether caloric restriction extends lifespan, and none realistically can: the trial would run for decades with an intervention almost nobody sustains. Human evidence is limited to surrogate measures over a few years.

§Variants

Sustained restriction is difficult, so most current interest is in schedules that reproduce parts of the signal intermittently.

Time-restricted eating confines intake to a window of roughly eight to ten hours. Randomized trials in humans have generally found weight loss no greater than with matched calorie reduction, and at least one found that a concerning share of the loss came from lean mass.⁶

Alternate-day and periodic fasting produce larger metabolic swings. In the largest controlled lifespan study in genetically diverse mice, both fasting schedules and graded restriction extended lifespan, and the most restricted group lived longest. The degree of metabolic improvement did not predict which animals lived longer, whereas traits related to resilience and genetic background did.⁷ That dissociation undercuts the common assumption that a favourable metabolic panel is the mechanism of benefit.

Fasting-mimicking diets use several days per month of a low-calorie, low-protein formulation intended to trigger fasting responses while permitting some food. Trials report improvements in cardiometabolic risk factors; claims of reduced biological age rest on the same surrogate measures whose validity is in question.

§Tradeoffs and risks

Restricted animals are cold-intolerant, slower to heal wounds, and more vulnerable to some infections and to physical stress. In humans the documented costs of sustained restriction include loss of bone density and lean mass, reduced strength, cold sensitivity, persistent hunger, reduced libido and menstrual disruption. The implications for reproductive function are rarely discussed alongside the longevity claims. Severe restriction interacts badly with the sarcopenia of later life, so the population most likely to want a geroprotector is also the population least suited to this one.

The effect is also not universal. In panels of genetically diverse mice, restriction shortens life in a minority of strains. There is no reason to assume humans are uniform where mice are not, and no biomarker exists to identify who responds.

Does the benefit shrink with lifespan?

Restriction gives a large proportional gain in short-lived species and a smaller, contested one in primates. One reading is that it triggers a famine-response programme whose payoff scales with how quickly an organism's reproductive schedule can be deferred; if so, a species that already lives eighty years has little left to gain. The question bears directly on how much weight dietary explanations of exceptional longevity deserve.

§Outlook

The practical work has moved away from restriction itself toward compounds that engage its downstream signalling without hunger: mTOR inhibitors, AMPK activators and the wider set of nutrient-sensing drugs discussed under the Geroscience hypothesis. Separately, GLP-1 receptor agonists have made sustained reductions in intake pharmacologically achievable, though they act mainly on excess adiposity and do not hold a lean animal below its normal intake. Comparative work on exceptionally long-lived species and on the genetics of restriction response may eventually explain why some individuals benefit and others do not.

The counterfactual that matters most for people remains unresolved: whether restriction adds anything to Healthspan in a well-nourished adult of normal weight, beyond what regular exercise and the avoidance of overfeeding already deliver. CALERIE was not designed to answer that, and no trial currently planned will.

§See also

• Autophagy
• Rapamycin
• Hallmarks of aging
• Exercise as a geroprotector
• Aging biomarkers
• Healthspan
• Blue Zones
• Geroscience hypothesis

§References